Papers
10
Total Citations
114
H-Index
6
About
Dr. Jian‐Ri Li is a leading urologic oncologist whose research bridges genetic susceptibility and surgical innovation in prostate and renal cancers. His work focuses on how long non‑coding RNA polymorphisms—particularly in GAS5, MALAT1, and H19—influence prostate cancer risk, progression, and lymph node metastasis. Notably, his 2019 study on GAS5 variant rs145204276 (27 citations) demonstrated that this polymorphism significantly affects prostate cancer susceptibility and clinicopathologic features, providing a potential biomarker for risk stratification. Dr. Li also pioneered the use of robotic surgery in urology, reporting the long‑term outcomes of robotic partial nephrectomy for renal angiomyolipoma (17 citations) and standardizing the robotic‑assisted radical prostatectomy procedure after 1,200 cases. His work on carbonic anhydrase 9 expression (15 citations) offers a novel predictor for nodal metastasis in patients with low PSA levels. With over 100 total citations, Dr. Li’s contributions have advanced both the molecular understanding of urologic cancers and the refinement of minimally invasive surgical techniques, directly impacting patient selection and treatment outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2Long-term outcome of robotic partial nephrectomy for renal angiomyolipoma17 citations · 2016
- 3
- 4
- 5Application in robotic urologic surgery14 citations · 2014
- 6
- 7
- 8
- 9
- 10